Runway Months
Live
Investors

Ultrahuman raises $70 million for healthtech

Ultrahuman raised $70 million from investors like Qualcomm Ventures to scale R&D and expand its health platforms worldwide.

Ultrahuman raised $70 million from investors like Qualcomm Ventures to scale R&D and expand its health platforms worldwide

Ultrahuman has raised $70 million, or nearly 662 crore rupees, in a new funding round. The smart ring manufacturer plans to use the capital to scale its research and development and expand its product offerings worldwide.

Participants in the round included Qualcomm Ventures, Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital. Including this round, the startup has now raised more than $173 million since its founding in 2019 by Mohit Kumar and Vatsal Singhal.

Funding for an integrated platform

The company stated the funding will help it move beyond wearables to build an integrated, AI-powered wellness platform. This platform aims to combine physiological, biochemical, and environmental data for a holistic health view.

A significant portion of the capital is earmarked for scaling research in sensing technology, artificial intelligence, miniaturized electronics, and health algorithms. The startup also plans to expand the global reach of its blood testing product, Blood Vision, and its continuous glucose monitoring platform, Ultrahuman M1.

"Building this requires us to go unusually deep across sensing, materials, electrical engineering, algorithms, physiology and clinical science," said Ultrahuman cofounder and CEO Mohit Kumar. "This capital lets us push much harder on it, and bring what we build to millions of people around the world."

The existing ecosystem and future plans

Ultrahuman's current health tracking ecosystem is built around its smart rings. The platform integrates data from the Ultrahuman Ring, Blood Vision, continuous glucose monitors, environmental sensors, and various software and AI tools.

The company aims to create a broader computing platform to continuously understand signals from the human body. These signals include sleep patterns, cardiovascular health, metabolism, hormonal rhythms, blood biomarkers, and recovery states.

The startup is also developing a software layer called PowerPlugs. This allows users to gain insights and add specialized health capabilities in areas like cardiovascular health, reproductive health, circadian alignment, respiratory health, and pregnancy. Earlier this year, Ultrahuman launched Pulsomics, an opt-in research platform that enables ring users to participate in large-scale studies using longitudinal real-world data.

Challenges and financial performance

The new funding arrives as Ultrahuman navigates several challenges. In March of this year, the company experienced a cybersecurity breach where hackers accessed personal information for some users. Ultrahuman said this led to a leak of wellness data for about 0.1% of its user base.

The company is also engaged in a legal dispute with Finnish competitor Oura in the United States. Last year, the US International Trade Commission ruled that Ultrahuman's smart rings infringed an Oura patent, resulting in a months-long import ban. Ultrahuman re-entered the US market in March 2026 with its Ring Pro, a redesigned device it claims addresses the patent issues.

Financially, the company reported a turnaround to profitability in the fiscal year 2025. According to the source, its financial performance for the recent fiscal years is as follows:

MetricFY24FY25
Operating Revenue₹104.6 Cr₹564.7 Cr
Net Profit/LossLoss of ₹37.7 CrProfit of ₹71.5 Cr

The broader wearable market context

The funding coincides with a shift in India's wearable market beyond basic fitness trackers. Startups are increasingly focusing on AI-powered preventive healthcare, recovery, and stress management. Consumer demand is reportedly surging for integrated platforms that span diagnostics, coaching, nutrition, and skincare.

This trend has attracted investor interest. In May, wearable startup Sychedelic raised $3.5 million in a seed round, while rival Gabit secured approximately 36.2 crore rupees. In March, healthtech startup Mave Health raised $2.1 million in a seed round led by Blume Ventures, and in February, Deepinder Goyal's wearables startup Temple raised $54 million.

The source cites a projection that the Indian healthtech market could become a $106 billion opportunity by 2033.

Related coverage

More from Investors